The Impact of War on Drug Supply Chain
Pharmaceutical Commerce
JUNE 10, 2022
A conversation with EY life sciences leaders Jim Welch and Jay Welsh.
Pharmaceutical Commerce
JUNE 10, 2022
A conversation with EY life sciences leaders Jim Welch and Jay Welsh.
Pharmaceutical Technology
JULY 19, 2022
Listed below are the impact of ESG on healthcare, as identified by GlobalData. The pharma industry, for example, has been plagued by issues relating to governance involving fraud, price-fixing, the unlawful promotion of drugs, and kickbacks. ESG: Covid-19 and the Ukraine crisis has led to a greater focus on supply chains.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
DECEMBER 27, 2022
Along the way, mergers and acquisitions continued to happen, new drugs and devices got approved, and innovations in the clinical trial industry were introduced. Along the way, mergers and acquisitions continued to happen, new drugs and devices got approved, and innovations in the clinical trial industry were introduced.
Pharmaceutical Technology
NOVEMBER 14, 2022
The value of the euro against the US dollar has also fallen in 2022, primarily due to sharply rising inflation caused by higher energy prices associated with the Russia-Ukraine war and low-interest rate rises compared to the dollar. Rishi Sunak became the British prime minister on October 25, 2022.
Drug Discovery World
OCTOBER 19, 2022
Clinic+ to understand the impact of the war and how the industry has been able to rebuild. . Despite this drop, the remaining 52% are continuing to recruit in the face of obvious challenges due to the ongoing war. . Russia invaded Ukraine on February 24, 2022. Ongoing clinical trials.
pharmaphorum
AUGUST 12, 2022
The COVID-19 pandemic led to skyrocketing demand for some products while simultaneously constraining supplies due to logistical breakdowns and protectionist practices. The logic of outsourcing production to other countries, primarily China, suddenly looked dubious as Western countries struggled to import the drugs they needed.
Roots Analysis
SEPTEMBER 1, 2023
While the former involves intense rivalry, limited innovation, and constant price wars, the latter represents a realm where innovation has no bounds, competition is irrelevant, and value creation is paramount. In the fiercely competitive landscape of the pharma and biotech industries, standing out from the crowd is crucial for success.
Let's personalize your content